Showing results (41-50 of 279) with videos related to
Sort By:
Pageof 28
Antimicrobial Agents and Chemotherapy|March 1, 1978
In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillinR Wise, J M Andrews, K A BedfordThe Journal of Antimicrobial Chemotherapy|October 3, 2001
Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpointR Wise, J M Andrews, J P AshbyThe Journal of Antimicrobial Chemotherapy|June 1, 1997
Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosaF J Boswell, J M Andrews, R WiseThe Journal of Antimicrobial Chemotherapy|June 25, 1999
Study to assess the reliability of a disc diffusion method for determining the sensitivity of gram-positive pathogens to dalfopristin/quinupristinJ M Andrews, J P Ashby, R WiseThe Journal of Antimicrobial Chemotherapy|November 1, 1990
In-vitro activity of cefodizime against respiratory pathogensR Wise, J M Andrews, J P AshbyThe Journal of Antimicrobial Chemotherapy|February 1, 1985
The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agentsR Wise, J M Andrews, L J PiddockAntimicrobial Agents and Chemotherapy|June 1, 1986
In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolitesR Wise, J M Andrews, L J PiddockAntimicrobial Agents and Chemotherapy|September 1, 1979
LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibioticsR Wise, J M Andrews, K A BedfordPostgraduate Medical Journal|January 1, 1979
Comparative in vitro microbiological activity and stability of cefaclorA P Gillett, J M Andrews, R WiseAntimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effectF J Boswell, J M Andrews, R WisePageof 28